DCL-08-083, CFR 26; Appendix a Notification, Subpart B, Section 2.8 (e)(4), Submittal of Report of Investigation Into an Unsatisfactory Performance Test Result Associated with Fitness for Duty Program

CFR 26; Appendix a Notification, Subpart B, Section 2.8 (e)(4), Submittal of Report of Investigation Into an Unsatisfactory Performance Test Result Associated with Fitness for Duty Program

ML082760401
Person / Time
Site:	Diablo Canyon
Issue date:	09/19/2008
From:	Becker J Pacific Gas & Electric Co
To:	Document Control Desk, Office of Nuclear Reactor Regulation
References
DCL-08-083
Download: ML082760401 (3)

Text

Pacific Gas and Electric.Companyu James R. Becker Diablo Canyon Power Plant Site Vice President and Mail Code 104/5/502 Station Director P.0. Box 56 Avila Beach, CA 93424 September 19, 2008 805.545.3462 Internal: 691.3462 Fax: 805.545.4234 PG&E Letter DCL-08-083 U.S. Nuclear Regulatory Commission ATTN: Document Control Desk Washington, D.C. 20555-0001 Docket No. 50-275, OL-DPR-80 Docket No. 50-323, OL-DPR-82 Diablo Canyon Units 1 and 2 10 CFR 26, Appendix A Notification

Dear Commissioners and Staff:

Pursuant to 10 CFR 26, Appendix A, Subpart B, Section 2.8 (e)(4), Pacific Gas and Electric Company (PG&E) is submitting the following report of an investigation into an unsatisfactory performance test result associated with the Diablo Canyon Power Plant (DCPP) Fitness For Duty (FFD) Program.

On August 11, 2008, a blind performance specimen processed at the Laboratory Corporation of America (LabCorp) testing facility was reported to the DCPP FFD Program Supervisor with a negative result. The performance sample had been spiked with phencyclidine (PCP), and a positive result should have been reported.

LabCorp was contacted regarding this false negative result. LabCorp provided a report which indicated that: "[d]uring the review and posting of results from the 2 batches, the PCP result for this specimen was inadvertently entered as negative instead of 40 ng/ml. A corrected report was issued on August 13, 2008 documenting the change from negative to positive at 40 ng/ml." Enclosed with this submittal is the report from LabCorp. The LabCorp report also indicates: "This-issue has been reviewed with the certifying scientist involved and training will be conducted with all certifying scientists regarding accurate entry of GC/MS results."

PG&E makes no regulatory commitments under this submittal.

If you have any questions regarding the information enclosed or other FFD Program activities, please contact William F. Ryan, Access/FFD Supervisor, at (805) 545-3329.

mSi cerely,c A member of the STARS (Strategic Teaming and Resource Sharing) Alliance Callaway a Comanche Peak

• Diablo Canyon

• Palo Verde

• South Texas Project ° Wolf Creek

. I PG&E Letter DCL-08-083

-Document September Control 19, 2008Desk Page 2 swh2 Enclosure cc/enc: Elmo E. Collins, NRC Region IV Michael S. Peck, NRC Senior Resident Inspector Alan B. Wang, NRC Project Manager A member of the STARS (Strategic Teaming and Resource Sharing) Alliance Callaway

• Comanche Peak

• Diablo Canyon

• Palo Verde

• South Texas Project

• Wolf Creek

-- * ' " **,¸,y " :.., "r' S 0 --- , -a-0n LaboratoroCorporation of America@.oldings

- PO Box 12652 Occupational Testing Services 1904 Alexander Drive Research Triangle Park, North Carolina 27709 Telephone: 800-833-3984 919-572-6900 August 29, 2008 William Ryan Pacific Gas and Electric Company Diablo Canyon Power Plant PO Box 56 Avila Beach, California 93424

Dear Mr. Ryan,

I received correspondence indicating that the result reported to you on a Blind Quality Control specimen was not consistent with the result you expected on the Blind QC sample per your manufacturer's Certificate of Analysis. Laboratory Corporation of America at Research Triangle Park, North Carolina reported P13559 (Lab Accession Number 0314705613) as negative yet the expected result was positive for PCP.

This specimen did yield a presumptive positive result on the initial test for PCP. It was extracted and analyzed by GC/MS in 2 different batches. During the review and posting of results from the 2 batches, the PCP result for this specimen was inadvertently entered as negative instead of 40 ng/mL. A corrected report was issued on August 13, 2008 documenting the change from negative to positive at 40 ng/mL.

This issue has been reviewed with the certifying scientist involved and training will be conducted with all certifying scientists regarding accurate entry of GU/MS results.

If I can be of further assistance to you, please do not hesitate to call me at 1-800-341-1150 X3254.

Sincerely, is K. Chandler Responsible Person